Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients.
Storci G, Barbato F, Ricci F, Tazzari PL, De Matteis S, Tomassini E, Dicataldo M, Laprovitera N, Arpinati M, Ursi M, Maffini E, Campanini E, Dan E, Manfroi S, Santi S, Ferracin M, Bonafe M, Bonifazi F. Storci G, et al. Among authors: maffini e. Front Immunol. 2023 Jan 13;13:1058739. doi: 10.3389/fimmu.2022.1058739. eCollection 2022. Front Immunol. 2023. PMID: 36713433 Free PMC article.
Extracellular vesicles as potential biomarkers of acute graft-vs-host disease.
Lia G, Brunello L, Bruno S, Carpanetto A, Omedè P, Festuccia M, Tosti L, Maffini E, Giaccone L, Arpinati M, Ciccone G, Boccadoro M, Evangelista A, Camussi G, Bruno B. Lia G, et al. Among authors: maffini e. Leukemia. 2018 Mar;32(3):765-773. doi: 10.1038/leu.2017.277. Epub 2017 Aug 30. Leukemia. 2018. PMID: 28852198 Free article.
Old age: the crown of life, our play's last act. Question and answers on older patients undergoing allogeneic hematopoietic cell transplantation.
Maffini E, Festuccia M, Ursi M, Barbato F, Dicataldo M, Roberto M, Campanini E, Dan E, De Felice F, De Matteis S, Storci G, Bonafè M, Arpinati M, Bonifazi F. Maffini E, et al. Curr Opin Hematol. 2023 Jan 1;30(1):14-21. doi: 10.1097/MOH.0000000000000743. Epub 2022 Nov 18. Curr Opin Hematol. 2023. PMID: 36539361 Review.
The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice.
Cerrano M, Ruella M, Perales MA, Vitale C, Faraci DG, Giaccone L, Coscia M, Maloy M, Sanchez-Escamilla M, Elsabah H, Fadul A, Maffini E, Pittari G, Bruno B. Cerrano M, et al. Among authors: maffini e. Front Immunol. 2020 May 12;11:888. doi: 10.3389/fimmu.2020.00888. eCollection 2020. Front Immunol. 2020. PMID: 32477359 Free PMC article. Review.
Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT).
Maffini E, Labopin M, Beelen DW, Kroeger N, Arat M, Wilson KMO, Bay JO, Ganser A, Martin H, Passweg J, Kottaridis PD, Yakoub-Agha I, Porras RP, Wagner EM, Esteve J, Lanza F, Nagler A, Mohty M. Maffini E, et al. Bone Marrow Transplant. 2022 Oct;57(10):1556-1563. doi: 10.1038/s41409-022-01748-w. Epub 2022 Jul 14. Bone Marrow Transplant. 2022. PMID: 35835997
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study.
Malagola M, Polverelli N, Martino M, Patriarca F, Bruno B, Giaccone L, Grillo G, Bramanti S, Bernasconi P, De Gobbi M, Natale A, Terruzzi E, Olivieri A, Chiusolo P, Carella AM, Casini M, Maffini E, Nozzoli C, Mazza P, Bassi S, Onida F, Vacca A, Falcioni S, Luppi M, Iori AP, Pavone V, Skert C, Carluccio P, Borghero C, Proia A, Selleri C, Rubini V, Sacchi N, Oldani E, Bonifazi F, Ciceri F, Russo D. Malagola M, et al. Among authors: maffini e. Transplant Direct. 2023 Feb 22;9(3):e1451. doi: 10.1097/TXD.0000000000001451. eCollection 2023 Mar. Transplant Direct. 2023. PMID: 36845852 Free PMC article.
Ruxolitinib in steroid refractory graft-vs.-host disease: a case report.
Maffini E, Giaccone L, Festuccia M, Brunello L, Buondonno I, Ferrero D, Boccadoro M, Dellacasa C, Busca A, Novero D, Bruno B. Maffini E, et al. J Hematol Oncol. 2016 Aug 8;9(1):67. doi: 10.1186/s13045-016-0298-6. J Hematol Oncol. 2016. PMID: 27502249 Free PMC article.
46 results